Fox Chase Cancer Center News

Fox Chase Surgeon Wins Award in Urology

PHILADELPHIA (February 18, 2016) — Robert G. Uzzo, MD, FACS, a nationally recognized leader in urologic oncology from Fox Chase Cancer Center–Temple Health, is the recent recipient of the 36th Annual Ralph E. Hopkins Jackson Hole Seminar Series in Urology Award.

VIEW STORY

Solved Protein Structure Holds Key To Much-Needed Therapies For Metabolic Disorder

PHILADELPHIA (February 16, 2016) – Phenylketonuria, also known as PKU, is the most common inherited disease affecting amino acid metabolism. In a study published February 15th in Proceedings of the National Academy of Sciences, Fox Chase Cancer Center – Temple Health researchers made tremendous strides toward that goal by shedding new light on the structure of phenylalanine hydroxylase (PAH)—the enzyme that is defective in PKU patients.

VIEW STORY

Understanding How an Anticancer Drug Works Can Pave the Way for Personalized Therapy

PHILADELPHIA (February 16, 2016) – Fox Chase Cancer Center – Temple Health researchers have identified a way forward for personalized cancer treatments for a wide range of cancers by understanding how to stimulate the activity of a potent anticancer protein called TRAIL. ONC201 not only stimulates TRAIL, but also the death receptor for TRAIL on tumor cells.

VIEW STORY

Ovarian Cancer: Who is at Risk? What are the Signs?

PHILADELPHIA (February 2, 2016) – While its overall incidence has decreased in recent years, ovarian cancer causes more deaths than any other cancer of the female reproductive system, ranking fifth in cancer deaths among women. This February, Fox Chase Cancer Center—Temple Health seeks to educate women on the risk factors and signs of ovarian cancer.

VIEW STORY

Junior Investigators Win Awards for Pilot Projects

PHILADELPHIA (January 22, 2016) – The  Fox Chase Cancer Center’s American Cancer Society Institutional Research Grant (IRG) Pilot Project Competition for Junior Investigators  was open to eligible junior faculty at Fox Chase Cancer Center or Temple University. 

VIEW STORY

Review by Fox Chase Cancer Center—Temple Health and Temple University School of Medicine Physicians Highlights Advances in Diagnosis and Treatment of Bile Ducts Cancers

PHILADELPHIA (January 22, 2016) – A multidisciplinary team of physicians from Fox Chase Cancer Center – Temple Health and the Temple University School of Medicine has compiled a comprehensive review of recent advances in the understanding, diagnosis, and treatment of bile ducts cancers (or cholangiocarcinomas). The review is published in the January 22nd issue of Cancer.

VIEW STORY